Increased arginase activity in cystic fibrosis airways (Q46706389)

24 December 2017

title

Increased arginase activity in cystic fibrosis airways (English)

1 reference

24 December 2017

0 references

5

1 reference

24 December 2017

author name string

Hartmut Grasemann

1

1 reference

24 December 2017

Raphael Schwiertz

2

1 reference

24 December 2017

Sonja Matthiesen

3

1 reference

24 December 2017

Kurt Racké

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

15 September 2005

1 reference

24 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

24 December 2017

volume

172

1 reference

24 December 2017

page(s)

1523-1528

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

The relationship between the free pool of proline and collagen content in human liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Decreased arginine bioavailability and increased serum arginase activity in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Endothelial activation and increased heparan sulfate expression in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

NO pathway in CF and non-CF children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Measurement of exhaled nitric oxide in children, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Regulation of enzymes of the urea cycle and arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

The human arginases and arginase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Cystic fibrosis lung disease: the role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Nitric oxide metabolites in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Exhaled nitric oxide increases following admission for intravenous antibiotics in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-253OC

10.1164/RCCM.200502-253OC

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

release_xxgewzalu5gcxosid37ook2cma

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xxgewzalu5gcxosid37ook2cma

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16166623

1 reference

24 December 2017